Wealthspire Advisors, L.P. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 197 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$3,000
+50.0%
370.0%0.00%
Q4 2018$2,0000.0%370.0%0.00%
Q3 2018$2,0000.0%370.0%0.00%
Q2 2018$2,0000.0%370.0%0.00%
Q1 2018$2,000
-33.3%
37
-5.1%
0.00%
Q4 2017$3,00039
+1850.0%
0.00%
Q3 2017$020.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Mesirow Financial Investment Management, Inc. 9,433$266,0001.14%
Global Alpha Capital Management Ltd. 258,946$7,305,0001.12%
Birch Grove Capital LP 50,791$1,433,0000.78%
1492 Capital Management LLC 25,003$705,0000.53%
INVESTMENT COUNSELORS OF MARYLAND LLC 321,975$9,083,0000.41%
THB ASSET MANAGEMENT 48,385$1,364,0000.38%
Regent Investment Management LLC 36,979$1,043,0000.32%
GLOBEFLEX CAPITAL L P 41,212$1,163,0000.31%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$1,001,0000.26%
Ranger Investment Management 124,763$3,520,0000.22%
View complete list of ANI PHARMACEUTICALS INC shareholders